Clinical Trials Browser

Phase 1/2 × Standard of Care × Genitourinary × Clear all

NCT07206056 2026-03-02

TulmiSTAR-01

Phase 1/2 Recruiting

Progressive Metastatic Castrate Resistant Prostate Cancer

NCT07053462 2025-07-08

CRISPR-Edited HLA Donor Kidney Transplant to Reduce Rejection Risk

Phase 1/2 Recruiting

Carcinoma, Renal Cell, Kidney Failure, Chronic, Renal Insufficiency